Tailoring Porphyrin Conjugation for Nanoassembly-Driven Phototheranostic Properties

Area of Science:

• Biomaterials Science
• Nanotechnology
• Photomedicine

Background:

• Lipoprotein mimetic nanostructures are versatile platforms for drug delivery and supramolecular assembly studies.
• Porphyrin incorporation into these structures enables multimodal imaging and phototherapy agents.
• The impact of porphyrin conjugation strategy on nanoparticle photophysical properties requires further investigation.

Purpose of the Study:

• To systematically investigate the effects of oleylamide and lipid porphyrin conjugates on the biophotonic properties of porphyrin-lipoprotein nanoparticles.
• To establish a rational design strategy for tailoring phototheranostic agents based on conjugate structure.

Main Methods:

• Synthesis and characterization of porphyrin-lipoprotein nanoparticles with oleylamide and lipid conjugates.
• In vitro and in vivo evaluation of photophysical properties, including fluorescence, photoacoustic imaging, and photodynamic therapy efficacy.
• Analysis of nanoparticle stability and aggregate formation.

Main Results:

• Oleylamide conjugation resulted in stable J-aggregates with strong photoacoustic contrast.
• Lipid conjugation yielded nanoparticles with effective fluorescence and photodynamic therapeutic properties.
• Conjugate structure significantly influences the resulting nanoparticle's biophotonic and therapeutic capabilities.

Conclusions:

• The choice of porphyrin conjugate structure is critical for designing effective lipoprotein-based phototheranostic agents.
• This study provides a framework for rational design of next-generation agents by tailoring nanoassembly and biophotonic properties.
• Specific conjugate selection allows for precise control over fluorescence, photoacoustic, and photodynamic therapeutic outcomes.